Related Experiment Video
Updated: Jan 21, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
Atorvastatin attenuates cardiac hypertrophy through AMPK/miR-143-3p/Bcl2 axis
Jingang Sun1, Cuicui Zhang1, Zhigang Zhang1
1Linyi Central Hospital, Yishui Linyi, China.
Insights
Atorvastatin protects the heart by inhibiting miR-143-3p, reducing cardiomyocyte apoptosis and cardiac hypertrophy. This mechanism involves activating the AMPK pathway and upregulating Bcl2 expression, thereby preventing heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Pharmacology
Background:
- Atorvastatin is a lipid-lowering drug with reported cardioprotective effects.
- The precise molecular mechanisms underlying atorvastatin's ability to attenuate cardiac hypertrophy and prevent heart failure remain largely unknown.
Purpose of the Study:
- To elucidate the mechanism by which atorvastatin mitigates cardiac hypertrophy and inhibits cardiac failure.
- To investigate the role of microRNA-143-3p (miR-143-3p) and Bcl2 in atorvastatin's cardioprotective effects.
Main Methods:
- Cardiac hypertrophy was induced in rats via transverse aortic constriction (TAC) and in cardiomyocytes using angiotensin II (Ang II).
- The expression of miR-143-3p and Bcl2 was analyzed, and the involvement of the AMP-activated protein kinase (AMPK) pathway was assessed.
- Atorvastatin's effects on cardiac structure, apoptosis, and molecular markers were evaluated.
Main Results:
- Atorvastatin significantly reduced TAC-induced heart weight increase and cardiomyocyte apoptosis.
- Atorvastatin inhibited the up-regulation of miR-143-3p by activating the AMPK pathway.
- Bcl2 was identified as a direct target of miR-143-3p, and its expression was inversely correlated with miR-143-3p levels.
Conclusions:
- miR-143-3p exacerbates cardiac hypertrophy and apoptosis by suppressing Bcl2 expression.
- Atorvastatin attenuates cardiac hypertrophy and prevents heart failure by inhibiting miR-143-3p via AMPK activation, leading to restored Bcl2 expression.
Abstract:
Atorvastatin is employed as a lipid lowering agent and its heart protective effect has been recently reported as well. However, the mechanism of atorvastatin in attenuating cardiac hypertrophy and inhibiting cardiac failure is unclear. In our study, cardiac hypertrophy was induced in rats using transverse aortic constriction (TAC) method and in cardiomyocytes using angiotensin II (Ang II). Atorvastatin significantly suppressed TAC-induced heart weight increase and cardiomyocytes apoptosis in rats. At a molecular level, we found that miR-143-3p was significantly up-regulated, and the up-regulation could be inhibited by atorvastatin via activating AMPK pathway. Furthermore, it was validated that Bcl2 was one of the target genes of miR-143-3p. Taken together, the data indicated that miR-143-3p aggravated cardiac hypertrophy by inducing cardiomyocytes apoptosis through inhibiting Bcl2 expression. This study demonstrated the effects of atorvastatin in attenuating cardiac hypertrophy and inhibiting cardiac failure, which is depending on Bcl2 expression via miR-143-3p inhibition by AMPK activation.
More Related Videos
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Hypothalamic-Pituitary Axis
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
Moment of Inertia about an Arbitrary Axis
In this scenario, the perpendicular distance between the chosen arbitrary axis...
Angular Momentum about an Arbitrary Axis
The velocity of a mass element comprises its translational velocity and the relative velocity instigated by the body's rotation. Substituting the velocity equation into...

